No lipiodol, no beads—another transcatheter arterial chemoembolization ( TACE ) with fine cisplatin powder and porous gelatin particles for TACE ‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma
Cancer Medicine · 2024
DOI: 10.1002/cam4.7446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Rui Sato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: Chemoembolization, Therapeutic, Carcinoma, Hepatocellular, Liver Neoplasms, Cisplatin. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
The Japanese Interventional oncology group (JIVROSG) showed the efficacy and safety of nonselective transarterial chemoembolization (TACE) with fine cisplatin powder (diamminedichloroplatinum; DDP‐H) (65 mg/m 2 ) and porous gelatin particles (DDP‐H TACE) without lipiodol for extensive multifocal hepatocellular carcinoma (HCC). However, there are no studies on this method following the JIVROSG study. Therefore, we aimed to evaluate the efficacy of this new DDP‐H TACE and its effect on liver function.
Methods
We retrospectively reviewed the medical records of TACE‐naïve patients with multifocal HCC (Child‐Pugh class A, up‐to‐seven out, no prior history of systemic therapy) who underwent whole‐liver DDP‐H TACE between January 2006 and December 2019.
Results
Sixty patients were included in this study. The median age of the patients was 71 (range, 35–88) years. The median maximum size of tumors was 26 (range, 8–184) mm; 86.7% of patients met the up‐to‐11 criteria out. The overall survival duration was 30.3 months. At the time of initial evaluation (median, 45 days), the overall response rate was 65.0%; the disease control rate was 86.7% based on the modified response evaluation criteria in solid tumors guideline. Although nine patients' liver function had deteriorated to Child‐Pugh class B at initial evaluation, six of them recovered to Child‐Pugh class A. Only three patients (5%) showed permanently impaired liver function.
Conclusions
Whole‐liver DDP‐H TACE without lipiodol or beads effectively reduced tumors and preserved liver function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Interventional Radiology, Shizuoka Cancer Center, Shizuoka, Japan.
- Molecular Gastroenterology and Hepatology, Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto, Japan.
ORCID-Profile: Rui Sato, Atsushi Saiga
Zitieren
APA
Sato, R., Moriguchi, M., Saiga, A., Asahara, K., & Aramaki, T. (2024). No lipiodol, no beads—another transcatheter arterial chemoembolization ( TACE ) with fine cisplatin powder and porous gelatin particles for TACE ‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.7446
Vancouver
Sato R, Moriguchi M, Saiga A, Asahara K, Aramaki T. No lipiodol, no beads—another transcatheter arterial chemoembolization ( TACE ) with fine cisplatin powder and porous gelatin particles for TACE ‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.7446
BibTeX
@article{Sato2024,
author = {Sato, Rui and Moriguchi, Michihisa and Saiga, Atsushi and Asahara, Kazuhisa and Aramaki, Takeshi},
title = {No lipiodol, no beads—another transcatheter arterial chemoembolization ( TACE ) with fine cisplatin powder and porous gelatin particles for TACE ‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7446}
}
EUVIMED